{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:08:51Z","timestamp":1747224531460,"version":"3.40.5"},"reference-count":5,"publisher":"PAGEPress Publications","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Reports"],"abstract":"<jats:p>Not available<\/jats:p>","DOI":"10.4081\/dr.2023.9734","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T13:42:09Z","timestamp":1692884529000},"source":"Crossref","is-referenced-by-count":1,"title":["Apalutamide-induced ichthyosiform eruption"],"prefix":"10.4081","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9098-4124","authenticated-orcid":false,"given":"Christian","family":"Ciolfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lunardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5014-1122","authenticated-orcid":false,"given":"Fortunato","family":"Cassalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"10222","doi-asserted-by":"crossref","unstructured":"Clegg NJ, Wongvipat J, Joseph JD et al. ARN-509: a novel antiandrogen for prostate cancer treatment. Cancer Res. 2012;72(6):1494-1503.","DOI":"10.1158\/0008-5472.CAN-11-3948"},{"key":"10223","doi-asserted-by":"crossref","unstructured":"Chi KN, Agarwal N, Bjartell A et al. Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer. N Engl J Med. 2019;381(1):13-24.","DOI":"10.1056\/NEJMoa1903307"},{"key":"10224","doi-asserted-by":"crossref","unstructured":"Smith MR, Saad F, Chowdhury S et al. Apalutamide and Overall Survival in Prostate Cancer. Eur Urol. 2021;79(1):150-158.","DOI":"10.1016\/j.eururo.2020.08.011"},{"key":"10225","doi-asserted-by":"crossref","unstructured":"Uemura H, Koroki Y, Iwaki Y et al. Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study. BMC Urol. 2020;20(1):139.","DOI":"10.1186\/s12894-020-00689-0"},{"key":"10226","doi-asserted-by":"crossref","unstructured":"Miyagawa F, Akioka N, Yoshida N et al. Psoriatic Skin Lesions after Apalutamide Treatment. Acta Derm Venereol. 2022;102:adv00659.","DOI":"10.2340\/actadv.v102.858"}],"container-title":["Dermatology Reports"],"original-title":[],"link":[{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9734\/9181","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9734\/9181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T13:42:14Z","timestamp":1692884534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/view\/9734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":5,"URL":"https:\/\/doi.org\/10.4081\/dr.2023.9734","relation":{},"ISSN":["2036-7406","2036-7392"],"issn-type":[{"type":"electronic","value":"2036-7406"},{"type":"print","value":"2036-7392"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}